Documenting HIV service delivery and adoption of evidence-based practices in HIV care programs: A protocol for a cross-sectional survey of HIV clinics participating in the International epidemiology Databases to Evaluate AIDS (IeDEA)
- 1Graduate School of Public Health and Health Policy, City University of New York, Institute for Implementation Science in Population Health
Abstract
IntroductionHIV care and treatment programs around the world continue to evolve in response to changes in clinical guidelines, evidence-based practices, domestic and donor funding for the HIV response, new technological developments, and changing weather patterns. Since 2009, the International epidemiology Databases to Evaluate AIDS (IeDEA) research consortium has conducted periodic surveys to document the characteristics of participating clinics and the availability of HIV-related services across diverse settings--information that provides important context for understanding variations and trends in HIV care outcomes. This paper describes the protocol for IeDEAs 2026 site assessment survey, launched in August 2026.
Methods and analysisThis cross-sectional descriptive study aims to document HIV-related services and practices among clinics in 42 countries. The survey explores the characteristics and services provided at HIV care and treatment sites participating in IeDEA in 2026, along with real-world adoption and implementation of evidence-based service delivery strategies for people living with or at risk of HIV. Designed for self-administration, the survey questionnaire was developed through two complementary processes: a review of questions and data collected through IeDEAs prior consortium-wide surveys and an open call to IeDEA investigators for new survey content to advance a timely implementation science agenda relevant to the global HIV community. Survey materials and links to an online REDCap questionnaire will be distributed to 235 eligible clinics across IeDEA in September 2026, with a deadline of November 30, 2026, for completion. Planned analyses will examine the following topics: HIV care amidst funding constraints; the roll-out of differentiated service delivery models; pre-exposure HIV prophylaxis; long-acting injectable antiretroviral therapy (ART); prevention, screening and/or treatment services for viral hepatitis, mental health and substance use disorders, cardiovascular disease, and cancers among PLHIV; the integration of HIV care with other health services; and clinic vulnerability to extreme weather events.
Ethics and disseminationA "non-human subjects" research designation was determined by the Vanderbilt University Medical Center Human Research Protections Program. Survey findings will be shared with local partners and stakeholders across IeDEA, disseminated at regional and global conferences, and published in peer-reviewed journals.
Strengths and limitations of this studyO_LIStrengths of this study include gathering data for a global cohort of 235 HIV clinics across 42 low-, middle- and high-income countries, reflecting real-world adoption and implementation of treatment guidelines and evidence-based practices for HIV prevention, care and management across diverse settings during a period of substantial changes in funding for the HIV response. Further strengths include a rigorous process for survey development that combined an in-depth review of data and findings from prior International epidemiology Databases to Evaluate AIDS (IeDEA) surveys with new investigator-driven content focused on implementation science questions related to the HIV response and key gaps in the literature. C_LIO_LIStudy limitations include potential recall and social desirability biases inherent in self-reported data, as well as selection biases that may determine clinic participation. Additionally, while clinics participating in the global IeDEA research consortium are reflective of real-world HIV care delivery, they may not be nationally or regionally representative. C_LI
Related
- Prescription-Duration Patterns of Outpatient Macrolide Use in Participating Community Pharmacies in Tokyo, Japan: A 24-Month Repeated Cross-Sectional Study
- Soy Consumption and the Risk of Developing Bladder Cancer: A Pooled Analysis of Cohort Studies from the International Pooled Bladder Cancer Epidemiology and Nutritional Determinants (BLEND) Study
- Exposure and impact: highlights from the second scientific conference and recent activities of the International Society of Radiation Epidemiology and Dosimetry (ISoRED)
- International variation in neuropsychological test use practices: Implications for test adaptation and fair assessment
- Contemporary Management and Rechallenge Practices for 5‐Fluorouracil–Associated Cardiotoxicity: Insights From an International Cardio‐Oncology Society Survey
BibTeX
@misc{brazier2026documenting,
title = {{Documenting HIV service delivery and adoption of evidence-based practices in HIV care programs: A protocol for a cross-sectional survey of HIV clinics participating in the International epidemiology Databases to Evaluate AIDS (IeDEA)}},
author = {E. Brazier and F. Maruri and S. N. Duda and K. Wools-Kaloustian and A. Freeman and B. Musick and S. Arabadjis and M. Ballif and N. V. Fernandez Villalobos and M. H. Kuniholm and K. Lancaster and S. Lujintanon and A. M. Parcesepe and R. A. Pellegrino and A. F. Ramos Menchelli and J. Ross and J. Ross and A. Semeere and D. Nash},
howpublished = {medRxiv},
year = {2026},
month = sep,
doi = {10.64898/2026.09.16.26363245},
url = {https://www.medrxiv.org/content/10.64898/2026.09.16.26363245v1},
note = {CC BY-NC},
}
RIS
TY - UNPB
TI - Documenting HIV service delivery and adoption of evidence-based practices in HIV care programs: A protocol for a cross-sectional survey of HIV clinics participating in the International epidemiology Databases to Evaluate AIDS (IeDEA)
AU - E. Brazier
AU - F. Maruri
AU - S. N. Duda
AU - K. Wools-Kaloustian
AU - A. Freeman
AU - B. Musick
AU - S. Arabadjis
AU - M. Ballif
AU - N. V. Fernandez Villalobos
AU - M. H. Kuniholm
AU - K. Lancaster
AU - S. Lujintanon
AU - A. M. Parcesepe
AU - R. A. Pellegrino
AU - A. F. Ramos Menchelli
AU - J. Ross
AU - J. Ross
AU - A. Semeere
AU - D. Nash
PY - 2026
DA - 2026/09/16
PB - medRxiv
DO - 10.64898/2026.09.16.26363245
UR - https://www.medrxiv.org/content/10.64898/2026.09.16.26363245v1
AB - IntroductionHIV care and treatment programs around the world continue to evolve in response to changes in clinical guidelines, evidence-based practices, domestic and donor funding for the HIV response, new technological developments, and changing weather patterns. Since 2009, the International epidemiology Databases to Evaluate AIDS (IeDEA) research consortium has conducted periodic surveys to document the characteristics of participating clinics and the availability of HIV-related services across diverse settings--information that provides important context for understanding variations and trends in HIV care outcomes. This paper describes the protocol for IeDEAs 2026 site assessment survey, launched in August 2026. Methods and analysisThis cross-sectional descriptive study aims to document HIV-related services and practices among clinics in 42 countries. The survey explores the characteristics and services provided at HIV care and treatment sites participating in IeDEA in 2026, along with real-world adoption and implementation of evidence-based service delivery strategies for people living with or at risk of HIV. Designed for self-administration, the survey questionnaire was developed through two complementary processes: a review of questions and data collected through IeDEAs prior consortium-wide surveys and an open call to IeDEA investigators for new survey content to advance a timely implementation science agenda relevant to the global HIV community. Survey materials and links to an online REDCap questionnaire will be distributed to 235 eligible clinics across IeDEA in September 2026, with a deadline of November 30, 2026, for completion. Planned analyses will examine the following topics: HIV care amidst funding constraints; the roll-out of differentiated service delivery models; pre-exposure HIV prophylaxis; long-acting injectable antiretroviral therapy (ART); prevention, screening and/or treatment services for viral hepatitis, mental health and substance use disorders, cardiovascular disease, and cancers among PLHIV; the integration of HIV care with other health services; and clinic vulnerability to extreme weather events. Ethics and disseminationA "non-human subjects" research designation was determined by the Vanderbilt University Medical Center Human Research Protections Program. Survey findings will be shared with local partners and stakeholders across IeDEA, disseminated at regional and global conferences, and published in peer-reviewed journals. Strengths and limitations of this studyO_LIStrengths of this study include gathering data for a global cohort of 235 HIV clinics across 42 low-, middle- and high-income countries, reflecting real-world adoption and implementation of treatment guidelines and evidence-based practices for HIV prevention, care and management across diverse settings during a period of substantial changes in funding for the HIV response. Further strengths include a rigorous process for survey development that combined an in-depth review of data and findings from prior International epidemiology Databases to Evaluate AIDS (IeDEA) surveys with new investigator-driven content focused on implementation science questions related to the HIV response and key gaps in the literature. C_LIO_LIStudy limitations include potential recall and social desirability biases inherent in self-reported data, as well as selection biases that may determine clinic participation. Additionally, while clinics participating in the global IeDEA research consortium are reflective of real-world HIV care delivery, they may not be nationally or regionally representative. C_LI
ER -